Stay updated on HexaBody-DR5/DR5 Safety Clinical Trial
Sign up to get notified when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.

Latest updates to the HexaBody-DR5/DR5 Safety Clinical Trial page
- Check3 days agoChange DetectedRevision text now shows v3.5.4, replacing v3.5.3. This reflects a minor platform update and does not change trial content or public information on the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a release or site metadata update rather than a change to the trial study content.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No other additions or deletions were identified.SummaryDifference0.1%

- Check60 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check96 days agoChange DetectedGastric cancer was added to the study's conditions. The page revision notes show an update to v3.4.2 and the removal of the prior funding-status notice (v3.4.1).SummaryDifference0.4%

Stay in the know with updates to HexaBody-DR5/DR5 Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.